Literature DB >> 9639500

The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention.

V Hack1, R Breitkreutz, R Kinscherf, H Röhrer, P Bärtsch, F Taut, A Benner, W Dröge.   

Abstract

The loss of body cell mass (bcm) in senescence and wasting is poorly understood. We now show that the plasma cystine/acid soluble thiol ratio, ie, an indicator of the redox state, is increased in old age and cancer patients and correlated with a decrease in bcm and plasma albumin. A cause/effect relationship was suggested by two independent studies with N-acetyl-cysteine (NAC). NAC caused an increase in the bcm of healthy persons with high plasma cystine/thiol ratios, and treatment of cancer patients with NAC plus interleukin-2 caused an increase in bcm, plasma albumin, and functional capacity. Albumin levels below 680 micromol/L were associated with an increase in body water. Our studies suggest that the shift in the redox state may contribute to the loss of bcm and may provide a quantitative guideline for therapeutic intervention. Treatment of cancer patients with thiol-containing antioxidants may improve the quality of life.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639500

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Oxidative stress and ageing: is ageing a cysteine deficiency syndrome?

Authors:  Wulf Dröge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

2.  Reduced extracellular phagocyte oxidative activity, antioxidant level changes and increased oxidative damage in healthy human blood as a function of age.

Authors:  Margarita L Alexandrova; Petyo G Bochev
Journal:  Age (Dordr)       Date:  2009-01-24

3.  Quantitative measurement of redox state in human brain by 31 P MRS at 7T with spectral simplification and inclusion of multiple nucleotide sugar components in data analysis.

Authors:  Jimin Ren; Craig R Malloy; A Dean Sherry
Journal:  Magn Reson Med       Date:  2020-05-09       Impact factor: 4.668

4.  Age-related anabolic resistance after endurance-type exercise in healthy humans.

Authors:  William J Durham; Shanon L Casperson; Edgar L Dillon; Michelle A Keske; Douglas Paddon-Jones; Arthur P Sanford; Robert C Hickner; James J Grady; Melinda Sheffield-Moore
Journal:  FASEB J       Date:  2010-06-14       Impact factor: 5.191

5.  Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis.

Authors:  Jacek Zachwieja; Marcin Zaniew; Waldemar Bobkowski; Ewa Stefaniak; Alfred Warzywoda; Danuta Ostalska-Nowicka; Agnieszka Dobrowolska-Zachwieja; Maria Lewandowska-Stachowiak; Aldona Siwińska
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

Review 6.  Cysteine/cystine redox signaling in cardiovascular disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2010-12-03       Impact factor: 7.376

Review 7.  Repression of gene expression by oxidative stress.

Authors:  Y Morel; R Barouki
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

8.  Effect of thiol antioxidant on body fat and insulin reactivity.

Authors:  Wulf Hildebrandt; Andreas Hamann; Holger Krakowski-Roosen; Ralf Kinscherf; Klaus Dugi; Roland Sauer; Sabrina Lacher; Nuria Nöbel; Anne Bodens; Vassiliki Bellou; Lutz Edler; Peter Nawroth; Wulf Dröge
Journal:  J Mol Med (Berl)       Date:  2004-03-06       Impact factor: 4.599

9.  A rapid LC-FTMS method for the analysis of cysteine, cystine and cysteine/cystine steady-state redox potential in human plasma.

Authors:  Jennifer M Johnson; Fredrick H Strobel; Matthew Reed; Jan Pohl; Dean P Jones
Journal:  Clin Chim Acta       Date:  2008-06-27       Impact factor: 3.786

10.  Long-term cysteine fortification impacts cysteine/glutathione homeostasis and food intake in ageing rats.

Authors:  Karine Vidal; Denis Breuillé; Patrick Serrant; Philippe Denis; Françoise Glomot; Fabienne Béchereau; Isabelle Papet
Journal:  Eur J Nutr       Date:  2013-10-18       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.